Skip to content
    Sherpa Healthcare Partners logo

    Sherpa Healthcare Partners

    Beijing, ChinaFounded 2018
    www.sherpahp.comLinkedIn
    HealthcareBiotech & Life Sciences

    Sherpa Healthcare Partners is a Beijing-based venture capital firm founded in 2018 that targets early- to growth-stage investments in biotech, life sciences, medical devices, and healthcare companies across China and the United States. The firm was founded by a team that previously worked together at one of China's leading venture capital firms.

    47% of their portfolio is in Biotech & Life Sciences. Deal activity increased 600% year-over-year (7 deals in the last 12 months). Their most common stage is series-a (42% of deals). Average disclosed round size is $64.7M (across 33 rounds with reported amounts).

    Find people at Sherpa Healthcare Partners on Goldilocks AI

    Portfolio

    29

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    7

    Team

    XO

    Xiangyu Ouyang

    Managing Partner

    RW

    Raymond W. Cohen

    Venture Partner

    YS

    Yina Shi

    Partner

    Z(

    Zhenyu (Luke) Zhang

    Partner

    CC

    Changzu Cai

    Director

    YZ

    Yinxiao Zhu

    PE Investment Financial Analyst

    XD

    Xuan Deng

    Healthcare Venture Investor

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    36 investments
    CompanyRoundAmountDate
    ClinChoice logoClinChoiceSeed$150MSep 2026
    Maxvax logoMaxvaxSeries B—Sep 2026
    AAlamar Biosciences, Inc.Ipo$219.9MApr 2026
    AvisiTechnologies logoAvisiTechnologiesSeries A$10.7MFeb 2026
    AAvisi Technologies Inc.Series A—Feb 2026
    Spiro Medical logoSpiro MedicalSeries A$67MJan 2026
    AAvisi Technologies Inc.Seed$10.7MJan 2026
    Link Cell Therapies logoLink Cell TherapiesSeries A$60MDec 2025
    AArchimedes Vascular, Inc.Series A$2.2MJun 2025
    Brise Pharmaceuticals logoBrise PharmaceuticalsSeries A$20MApr 2024
    AAlamar Biosciences, Inc.Series C$128MFeb 2024
    ZWI Therapeutics, Inc. logoZWI Therapeutics, Inc.Series A$10MJan 2024
    Grit Bio logoGrit BioSeries B$60MSep 2023
    Changing Biotech logoChanging BiotechSeries A$22MJul 2022
    ClinChoice logoClinChoiceSeries E$150MJul 2022
    Cataya logoCatayaSeries A$16MJul 2022
    TTherorna Inc.Series A$42MJun 2022
    Fuse Biotherapeutics, Inc logoFuse Biotherapeutics, IncSeed$9.5MNov 2021
    Alebund logoAlebundSeries B$54.5MSep 2021
    Bota Bio logoBota BioSeries B$100MJul 2021
    Bota logoBotaUnknown$100MJul 2021
    Appia Bio logoAppia BioSeries A$52MMay 2021
    Edigene logoEdigeneSeries B—Apr 2021
    VVisenSeries B$150MJan 2021
    BBota BiosciencesSeries B$100MJan 2021
    Page 1 of 2

    Top Co-Investors

    LAV6 shared
    HongShan5 shared
    Source Code Capital5 shared
    MPC4 shared
    Accanto Partners3 shared
    Good Growth Capital3 shared
    Golden Seeds3 shared
    IDG Capital3 shared
    5Y Capital3 shared
    Morningside3 shared
    Decheng Capital2 shared
    Apricot Capital2 shared
    Draper Associates2 shared
    Legend Capital2 shared
    BioTrack Capital2 shared
    Samsara BioCapital2 shared
    Northern Light Venture Capital2 shared
    Hillhouse Investment2 shared
    Eight Roads2 shared
    Bits x Bites2 shared

    Last updated: 20 October 2026